This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information

WCLC, Barcelona, Spain 7-10 September 2019

Afatinib in EGFR mutation-positive NSCLC harbouring uncommon mutations: experience in ‘real-world’ clinical practice

Wolfgang Brückl, Eckart Laack, Christopher Hoffmann, Caicun Zhou, Yi-Long Wu

wclc_2019_uncommon_mutations_.jpg

Related Materials

Learn more about the science behind this poster in the videos, papers and other materials below.

UNCOMMON EGFR MUTATIONS

Go to Page

FOR HEALTHCARE PROFESSIONALS ONLY.

image